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WHAT THIS PAPER ADDS
 This is the second Vascunet report on carotid surgery including previously unpublished comparison of vascular surgical practice in
nine countries in Europe and Australia. The comparison includes estimations of effectiveness of current practice and utility of
carotid endarterectomy (CEA). Vascunet data give a possibility to identify differences in inclusion criteria and thus give a reﬂection
of real-life vascular service in these countries. Time trends in proportions of carotid artery stenting (CAS) versus CEA may also be
identiﬁed.a r t i c l e i n f o
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Objectives: The aim of the study was to analyse variation in carotid surgical practice, results and effec-
tiveness in nine countries.
Patients and Methods: A total of 48,185 carotid endarterectomies (CEAs) and 4602 carotid artery stenting
(CAS) procedures were included in the comparison. A theoretical effectiveness of CEA provision for each
country was estimated.
Results: 92.6% of the CEAs were performed according to the inclusion criteria based on the current
European recommendations and had a theoretical beneﬁt for the patient. The indication for surgery was
symptomatic stenosis in 60.1% and this proportion varied between 31.4% in Italy and 100% in Denmark.
The overall combined stroke and death rate in symptomatic patients was 2.3%. This varied between rates
of 0.9% in Italy and 3.8% in Norway. The overall combined stroke and death rate in asymptomatic patients
was 0.9%. It was lowest in Italy at 0.5%, and highest in Sweden at 2.7%. We estimated that the stroke
prevention rate per 1000 CEAs varied from 72.9 in Italy to 130.8 in Denmark.
Conclusions: There is signiﬁcant variation in clinical practice across the participating countries. The
theoretical stroke prevention potential of CEA seems to vary between participating countries due to
differences in the inclusion criteria.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.stions on this paper, please go to www.vasculareducation.com and click on ‘CME’
x: þ358 9 471 73548.
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ciety for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
ular and Endovascular Surgery 44 (2012) 11e17Introduction Material and MethodsP. Vikatmaa et al. / European Journal of Vasc12VASCUNET is a joint venture of vascular registries from Europe
and Australasia, administered and funded by the European Society
for Vascular and Endovascular Surgery (ESVS). Since the ﬁrst VAS-
CUNET meeting in 1997 the registry has been developing and two
general database reports have been published.1,2 As part of the third
report an analysis of abdominal aortic aneurysm treatment and CEA
outcome data from 2003 to 2007 have been published.3,4
The aim of carotid endarterectomy (CEA) is to prevent strokes.
During the last two decades, large randomised trials have clariﬁed
the indications for carotid intervention. The ESVS guidelines on
carotid surgery were published in 2009.5 According to the
recommendations CEA for symptomatic carotid stenosis exceeding
50% is indicated if the complication rates remain low. The
evidence base suggests that greatest beneﬁt is seen if the opera-
tion is performed soon after the onset of symptoms. National
guidance has been developed in most countries, such as the
National Institute for Clinical Excellence (NICE) in the UK that
recommends intervention within 2 weeks of the ﬁrst symptom
and the Department of Health has set a target of reaching a 48-h
delay before 2017 (www.dh.gov.uk/en/Publicationsandstatistics/
Publications/PublicationsPolicyAndGuidance/DH_081062).
The indications for surgery for asymptomatic stenosis are less
clear, because the risk of stroke for patients with asymptomatic
carotid stenosis is low. At present, the guidelines state that surgery
is indicated in younger patients (<75 years) and males seem to
beneﬁt more from CEA. Another controversial issue is the role of
carotid artery stenting (CAS). However, recent larger trials, ICSS6
and CREST,7 showed that the risk of stroke is signiﬁcantly higher
after stenting than after CEA, especially for symptomatic
patients.8,9 In a recent pooled analysis of 3433 randomised patients
CEA was safer in the short term than stenting, because of an
increased risk of stroke associated with stenting in patients over
the age of 70 years, but no difference was apparent in younger
patients.10
High-quality CEA provision cannot be reached without quality-
control methods. The guidelines are based on randomised
controlled trials (RCTs) whenever possible. However, actual prac-
tice is seldom a clean reﬂection of RCT recommendations. It is
important to knowhowwell the actual practice compareswith trial
recommendations. Registries reﬂect actual clinical practice,
although low rates of case ascertainment may introduce reporting
bias. Registries can also demonstrate adherence (or not) to clinical
evidence. Finally, they permit analysis of geographic variation in
clinical practice. This may reﬂect socio-economic differences or
differing cultural interpretation of the evidence base. National
administrative data sets may provide some information, but may
lack critical clinical data about the pathway of care. Clinical and
scientiﬁc registries address more speciﬁc questions for quality
control and research. A signiﬁcant concern with registered data is
reliability. Comparison of case ascertainment against national
statistics and validation of data quality is the ideal but seldom
achieved in clinical practice. The problem is compounded when
trying to compare national data sets due to differing cultures, and
national legislation around patient privacy. Despite these ﬂaws,
registries aid harmonisation and standardisation of national data
sets and can indicate where outlying behaviour may affect patient
safety (see www.aaaqip.com).11,12
This study analyses data on CEA in eight European countries and
Australia between 2005 and 2010. We look particularly at variation
between countries, with emphasis on the effectiveness of CEA
provision. Our ﬁnal aim is to examine how well European guide-
lines are implemented in practice and to identify factors that affect
their implementation.Case ascertainment
Data on CEAs and CASs from nine national or regional vascular
registries were collected and amalgamated using common data sets
accepted by all participants. Datawere collected from 2005 to 2009.
Australia, Denmark, Finland, Norway, Sweden and the United
Kingdom included data from all 5 years. In addition, the UK
included data from year 2010. Norway and Switzerland reported
data for 2005e2008, Italy for 2007e2009 and Hungary from 2008
to 2009. The data from Finland and Australia are from regional and
the others are from national registries. The variables and distribu-
tion of data included in the data set are presented in Tables 1 and 2
and patient demographics in Table 3.
Stratiﬁcation of patients for analysis
Data were available for 53,077 carotid artery procedures; these
were analysed overall and by country. Due to the differences in the
registries, not all data were available from all countries. The main
focus was to evaluate the differences between the nine countries in
patient demographics, co-morbidities, indications, operative data,
outcome and effectiveness. Due to the small proportion of CAS,
these were not included in the general analysis on outcome and
effectiveness reported below, but CAS patients were included in the
univariate analysis and the binary logistic regression model. Data
on CEAs were divided into asymptomatic and symptomatic
patients in the outcome analysis. To evaluate the effectiveness of
carotid surgery, CEA procedures were again divided into three
categories reﬂecting the data derived from large RCTs13,14 and
explained in more detail in discussion. These are:
1. Highly effective, which included all symptomatic men with
carotid artery stenosis 50% and symptomatic women 75
years of age with a stenosis 50%.
2. Moderately effective, which included symptomatic and asymp-
tomatic <75-year-old women with 50% stenosis and
asymptomatic men with a stenosis 50%.
3. Not effective, which included all patients with a stenosis <50%
and 75-year-old asymptomatic women.
To assess the effectiveness of this division of patients, we
calculated the crude number of strokes prevented per 1000 oper-
ations for each group: This gave estimates of 150, 75 and 0 for each
of groups 1, 2 and 3, respectively.13,14 These numbers were used in
the subsequent calculations given below.
Statistical analysis
Continuous data are presented as mean values and standard
deviation (SD); proportions are presented as percentages with 95%
conﬁdence intervals (CIs). CAS patients were included in the year-
by-year report on procedure amounts (Table 2), univariate anal-
ysis and the logistic regression model (Table 6), but excluded in
other analyses (Tables 3e5).
To evaluate the risk factors for combined stroke and death rate
30 days after the CEA or CAS, a univariate analysis was performed
including pre- and perioperative variables with less than 30% of
missing data and included in at least 8/9 national registries. Vari-
ables that reached p < 0.2 in the univariate analysis were included
in a binary logistic regression model, and the included variables
were indication, admission mode, procedure and country.
To estimate the effectiveness of interventions in each country,
the proportion of patients in each of our three categories was
Table 1
Data collected included in the Vascunet database on carotid endarterectomies and stentings.
Australia Denmark Finland Hungary Italy Norway Sweden Swizerland UK
Fields
Country         
Hospital ID         
Patient age         
Patient ID         
Gender         
Pre-operative data
Admission date        
Admission mode        
Time event  
Time of most recent event  
Diabetes         
Cardiac history         
Current smoker        
Pulmonary history        
Hypertension history        
Indication         
Grade stenosis (NASCET)       
Grade contra stenosis   
Previous ipsiiateral intervention      
Preop rankin score   
Operative data
Procedure         
CEA type        
CEA patch         
CEA shunt      
Operation date         
ASA grade        
Anaesthetic       
Post-operative data
Haemorrhage         
Nerve injury         
TIA         
Stroke         
Myocardial infarction         
30 day status        
Discharge date        
Date of death 
Cause of death  
Return to theatre within 30 days     
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was estimated for each country. We used the highest value
obtained (131/1000 for Denmark) as a reference, with all other
countries being given a proportional effectiveness value.
Statistical evaluation was made using SPSS 17.0 software (SPSS
Inc.; Chicago, IL, USA). Continuous variables are reported as the
mean  standard deviation. Cox proportional hazard model was
used as a multivariate analysis to ﬁnd independent risk factor for
poor outcome after the carotid procedure. Predictors of end point
were identiﬁed on univariate screen using p < 0.2 as threshold forTable 2
The number of registered carotid endarterectomies (CEA) and carotid artery stentings (C
2005 2006 2007 2008
CEA CAS CAS% CEA CAS CAS% CEA CAS CAS% CEA
Australia 452 76 14.4 422 72 14.6 401 67 14.3 484
Denmark 288 0 0 334 0 0 346 0 0 402
Finland 144 0 0 136 0 0 180 15 7.7 229
Hungary 3 0 0 1 0 0 1 0 0 624
Italy 0 0 0 0 0 0 6781 1356 16.7 6064
Norway 300 14 4.5 342 12 3.4 361 9 2.4 354
Sweden 922 43 4.5 1036 80 7.2 931 90 8.8 1097
Swizerland 424 0 0 447 6 1.3 480 4 0.8 465
United
Kingdom
235 0 0 2912 0 0 2747 17 0.6 4079
Total 2768 133 4.6 5630 170 2.9 12,228 1558 11.3 13,798
CEA ¼ carotid endarterectomy; CAS ¼ carotid artry stenting.
a Includes numbers from year 2010 in the data from Unided Kingdom (1521 CEAs andthe inclusion in a Cox regression model. Pearson’s chi-square test
was used for univariate analysis and for comparing proportions.
Values for p < 0.05 were considered signiﬁcant.
Results
The data include 53,077 carotid procedures, 48,185 CEAs and
4602 CASs (Table 2). When comparing the results from an indi-
vidual country to the mean ﬁgures it should be noted that Italy and
UK present by far the largest numbers of treated patients. TheAS) in the countries participating in the Vascunet registry during 2005e2010.
2009(e2010a) Invalid
data
All countries
CAS CAS% CEA CAS CAS% % CEA CAS CAS% Total
59 10.9 451 18 3.8 0 0 2210 292 11.7 2502
0 0 458 1 0.2 0 0 1828 1 0.1 1829
8 3.4 255 9 3.4 0 0 944 32 3.3 976
23 3.6 635 21 3.2 99 7.0 1264 44 3.7 1407
1495 19.8 4782 871 15.4 0 0 17,627 3722 17.4 21,349
5 1.4 0 0 0 0 0 1357 40 2.9 1397
86 7.3 1104 71 6.0 5 0.1 5090 370 6.8 5465
0 0 0 0 0 0 0 1816 10 0.5 1826
34 0.8 6076 40 0.7 186 1.1 16,049 91 0.6 16,326
1710 11.0 12,236 1027 7.7 290 0.5 48,185 4602 8.7 53,077
4 CASs) and Hungary (4 CEAs).
Table 3
Indications, admission mode, age, gender, risk factors, type of operation and anaesthesia mode in carotid endarterectomy patients.
Australia Denmark Finland Hungary Italy Norway Sweden Swizerland UK
D.m. (%) D.m. (%) D.m. (%) D.m. (%) D.m. (%) D.m. (%) D.m. (%) D.m. (%) D.m. (%)
Indication
asymptomatic (%)
33.1 0.3 0.0 1.3 15.6 1.1 46.1 9.2 68.6 0.0 20.5 0.0 22.8 0.1 40.4 0.0 16.8 1.2
Admission mode
emergency (%)
24.6 0.3 3.7 0.1 7.0 0.6 10.2 6.2 2.1 0 5.5 0 9.3 35.8 N.a. 10.9 1.3
Mean age (SD) 72.4
(9.0)
0.0 67.9
(9.1)
0.0 68.4
(9.1)
0.0 65.9
(9.0)
0.0 72.2
(8.4)
0.0 68.2
(9.0)
0.0 70.7
(8.5)
0.0 70.6
(9.0)
0.0 72.7
(9.5)
0.0
>75 years (%) 44.7 0.0 25.4 0.0 26.5 0.0 18.7 0.0 43.4 0.0 26.5 0.0 33.8 0.0 38.1 0.0 45.6 0.0
Female (%) 29.4 0.0 32.3 0.0 31.4 0.0 39.0 0.0 31.8 0.0 33.1 0.0 32.0 0.0 28.8 0.0 31.1 0.0
Diabetes (%) 24.7 3.7 14.2 0.2 38.7 4.3 29.8 77.6 29.5 0.0 15.6 0.0 20.0 2.8 24.4 0.0 20.2 0.9
Cardiac history (%) 49.8 4.0 26.5 0.2 42.6 4.1 47.0 77.6 51.0 0.0 37.6 0.0 37.7 4.2 39.6 0.0 30.6 1.1
Hypertension
history (%)
84.4 3.8 63.9 0.7 57.2 3.6 20.2 77.6 87.0 0.0 61.5 0.0 75.6 3.5 80.0 0.0 N.a.
Current smoker (%) 14.8 4.7 42.3 0.9 34.6 7.4 58.1 77.6 16.3 0.0 37.9 0.0 32.8 12.4 53.4 0.0 N.a.
Pulmonary
history (%)
N.a. 9.5 0.4 32.4 5.0 13.7 77.6 17.0 0.0 8.9 0.0 9.8 7.4 8.4 0.0 N.a.
Use of patch (%) 85.1 29.1 38.8 0.0 37.4 0.1 5.4 1.5 100.0 69.1 61.7 0.0 40.1 2.7 70.0 0.0 68.9 2.9
Local anaesthesia
(%)
29.5 0.6 66.6 0.5 41.4 85.7 21.9 77.6 51.3 0.0 N.a. N.a. 57.5 5.5 49.8 1.1
Eversion (%) 22.2 6.0 27.3 46.7 1.4 85.7 88.6 3.6 62.8 51.0 0.0 0.0 28.3 67.2 N.a. 7.3 3.2
D.m. ¼ Data missing; N.a. ¼ not applicable.
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Denmark (0.1%). Mean agewas 71.7 (SD 9.1) years. Themean age for
CEA patients was lowest in Hungary (65.9 years, SD 9.0), and
highest in the UK (72.7 years, SD 9.5) (p< 0.001). The proportion of
CEA patients older than 75 years varied from 18.7% in Hungary to
45.6% in the UK (p< 0.001). The proportion of womenwho had CEA
was highest in Hungary (39.0%) and lowest in Switzerland (28.8%)
(p < 0.001). All countries reported the indication for surgery as
symptomatic or asymptomatic. The indication for surgery was
symptomatic stenosis in 60.1% and this proportion varied from
100% in Denmark to 31.4% in Italy (p < 0.001). All countries but
Switzerland included admission mode; 6.8% of patients were
operated as emergency and the proportion of emergency opera-
tions varied from 2.1% in Italy to 24.6% in Australia (p < 0.001). The
emergency admission for all countries varied between 4.6% and
8.5% during 2005e2009 and there was no systematic increase over
time. The prevalence of risk factors is presented in Table 3.
The combined stroke and death rate in asymptomatic patients
was 0.9% and it was lowest in Italy, 0.5% and highest in Sweden,
2.7%. The combined stroke and death rate in symptomatic patients
was 2.3% and it varied between 0.9% in Italy and 3.8% in Norway
(Table 4).
Five countries (Australia, Denmark, Italy, Switzerland and the
UK) reported the mode of anaesthesia (general anaesthesia or local
anaesthesia). In these countries, the proportion of local/regionalTable 4
Death and/or stroke rate in asymptomatic and symptomatic carotid endarterectomy pat
Australia Finland Hungary Italy
Asymptomatic all 0.9 2.0 2.1 0.5
Female 1.4 0.0 3.7 0.5
Male 0.6 2.5 1.0 0.5
>75 years 1.0 0.0 2.6 0.6
<75 years 0.3 2.4 2.0 0.4
Australia Denmark Finland Hungary
Symptomatic 2.1 3.7 1.9 3.4
Female 2.2 4.0 3.9 3.1
Male 2.0 3.5 1.0 3.6
>75 years 2.6 5.0 0.9 3.4
<75 years 1.6 3.2 2.3 3.4
Emergency 3.1 6.0 3.0 4.1
Elective 1.5 3.6 1.8 3.3anaesthesia was 44.7% varying from 20.2% in Australia to 66.2% in
Switzerland. Patch was used in 50.5% and it varied from 5.6% in
Hungary to 70.4% in Switzerland (Table 3).
In the estimation for theoretical effectiveness of CEA provision
in each country the strokes prevented per 1000 operations varied
from 72.9 in Italy to 130.8 in Denmark (Table 5). The proportion of
patients that were operated according to European Society for
Vascular Surgery guidelines for carotid surgery5 was 92.3% and
varied from 70.3% in Italy to 100.0% in Denmark (Fig. 1).
In multivariate logistic regression model the independent
predictors for combined 30-day death and/or stroke rate were
symptomatic stenosis (OR 1.37, 95% CI 1.14e1.63), CAS versus CEA
(OR 1.78, 95% CI 1.36e2.33), admission mode emergency (2.04, 95%
CI 1.68e2.49) and country (Table 6).
Discussion
Inclusion criteria
We found clear differences in the practice of carotid surgery in
the participating countries. Outcome data are often presented
without a critical description of the inclusion criteria. We tried to
avoid this by calculating a theoretical effectiveness of the CEA
provision in each country. From the community point of view, to
make use of the full stroke preventing potential of CEA, the NNTients.
Norway Sweden Switzerland UK Total
2.5 2.7 1.6 1.8 1.0
3.8 2.3 1.0 1.4 0.9
2.0 2.9 1.9 1.9 1.0
0.0 4.2 2.8 1.5 1.0
3.2 2.5 1.0 2.0 1.0
Italy Norway Sweden Switzerland UK Total
0.9 3.8 3.0 3.4 2.4 2.4
0.7 2.5 3.4 5.6 2.5 2.5
1.0 4.5 2.8 2.5 2.4 2.3
0.9 2.4 3.3 3.8 2.4 2.4
0.9 4.4 2.7 3.1 2.5 2.4
3.8 7.0 3.5 N.a. 3.6 3.6
0.7 3.6 2.5 N.a. 2.3 2.1
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Table 6
Risk factors for combined death and/or stroke rate within 30-days after the proce-
dure (binary logistic regression model including all 53 077 patients).
Denmark 1.37 1.05e1.79 0.022
Finland 0.79 0.50e1.23 0.288
Hungary 1.05 0.73e1.49 0.802
Italy 0.26 0.21e0.33 0.000
Norway 2.02 1.49e2.72 0.000
Sweden 1.02 0.81e1.28 0.871
Switzerlanda 1.54 1.14e2.09 0.005
Indication Reference
Asymptomatic
Symptomatic 1.37 1.14e1.63 0.001
Procedure Reference
CEA
CAS 1.78 1.36e2.33 0.000
Admission mode Reference
Elective
Emergency 2.04 1.68e2.49 0.000
a Themodel excludes variables if over 30% of data is missing, admissionmodewas
not reported from Switzerland and all these cases are assumed to be elective.
Therefore OR from Switzerland may be an overestimation.
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however, the situation is different. The individual patient’s interest
is to have the least possible risk of stroke or recurrent stroke either
with an operation or without it. In this perspective, surgery may be
justiﬁed even in a less ‘effective’ setup. Thus, the differences should
be interpreted with caution. In the most effective setup, some
patients will have stroke, which might have been prevented by CEA
and in the least effective group many patients will take the risk of
unnecessary surgery.
In our calculations of theoretical effectiveness of the CEA we
categorised the patients using available data into subgroups
derived from the published NNT ﬁgures from the large RCTs.13,14We
used the complication ﬁgures reported in the RCTs for all countries
due to the fact that the registry-based data carry a risk of missing
complications and thus reports may underestimate the complica-
tion rate. Also, this underestimation can be different in different
countries. It should be recognised, however, that this method may
underestimate the effectiveness of CEA in stroke prevention in
those countries, regions or centres that have a lower complication
rate. The numbers in Table 5 provide crude estimates. While the
actual derived ﬁgures of strokes prevented by 1000 operations
might vary with different calculations, we propose that the data are
valid if it is accepted that group 2 has half the stroke prevention
potential of group 1. We believe that group 3 represents clearly
unnecessary operations, without demonstrable patient beneﬁt; for
example, the inclusion of younger asymptomatic women in group 2
might be discussed, but, on the other hand, there is limited
evidence on the matter that no asymptomatic women should be
operated.5 The ESVS guidelines state that women have less beneﬁt
from CEA. A signiﬁcant drawback of these calculations is the lack of
data on delay from symptom to surgery, which is alongwith age the
most important variable in the effectiveness. We were also not able
to separate high grade from moderate stenosis using the data
provided. However, the imagingmodalities have changed over time
and the asymptomatic trials did not show a difference between the
signiﬁcant stenosis groups and thus a reported 50% stenosis may be
justiﬁed as a turnover point.
According to the ESVS guidelines, patients are considered
symptomatic if they have suffered a carotid distribution TIA
(including ocular TIA) or non-disabling stroke in the preceding 6
months. All participating countries adhere to these deﬁnitions.
Some countries have validated their data in this respect, others
have not, but we did not have the exact ﬁgures to analyse potential
differences in the symptoms.
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Figure 1. The proportional effectiveness of carotid provision divided into three levels for each country. 1. (Highly effective): 50% stenosis symptomatic men, 50% stenosis
symptomatic female 75 years old. 2. (Moderately effective): 50% stenosis in asymptomatic men, 50% stenosis in symptomatic female <75 years old, <75 asymptomatic female
with 50% stenosis. 3. (Not effective): <50% stenosis, asymptomatic stenosis in female 75 years. D.m. ¼ data missing.
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them were asymptomatic. Italy and the UK represent together
37 675 CEA (i.e., 71% of all CEA). Mean, total and multivariate
analysis data outputs are mainly affected by data from these two
countries and therefore the data are presented separately for each
country when applicable.
Asymptomatic patients over 75 and patients with a stenosis less
than 50%were classiﬁed as unnecessary operations. In Denmark, no
asymptomatic patients were reported. Thus, although 100% of the
operations performed in Denmark were performed as suggested in
the ESVS guidelines, it may not be said that the Danish indications
would be in 100% accordancewith the ESVS guidelines.5 Indications
for intervention seem to be the strictest in Denmark, while most
countries seem to have somewhat softer inclusion criteria. Despite
the ESVS guidelines there is a lack of consensus about the indica-
tions for intervention in this audit.
A recent Medicare report of 538 958 carotid procedures repor-
ted that CAS was performed in 10.5% which compares with our
0.1e17.4% and reﬂects the fact that CAS has not replaced CEA as the
method of choice.15
Registry-based data are always incomplete and the complica-
tion rates might be different if controlled more meticulously.16 As
could be expected, complication rates are lower in Italywheremore
asymptomatic patients are operated on.
Validation
All registry-based studies have limitations and our report
demonstrates these. While data were submitted for analysis to
a central registry using agreed data sets, wewere not able to control
data validation for each country. Comparison to national statistics is
only routinely carried out in a few countries (Sweden, Denmark and
Finland), so completeness of data can only be estimated from
comparison to national statistics, where available. External inde-
pendent data validation is undertaken by Swedvasc,12 Denmark
(www.karbase.dk) and locally in Helsinki.11 UK data are compared
to national HES statistics, but not all cases are entered into the UK
data. We know that incomplete data are likely to contain bias
towards under-reporting poor outcomes. We recommend that
national audits should incorporate some form of validation to allow
external observers to form valid opinions about the accuracy of the
data presented. European standards for data reporting wouldimprove our ability to make treatment and outcome comparisons
between countries.
In addition to incomplete reporting, there were signiﬁcant
numbers of variables missing from parts of the data set. We chose
to exclude the variables where over 30% of the data were missing.
Improving both the number of cases submitted and the
completeness of the data set are key steps to improving the value
of registry data.Utility of CEA
Table 5 presents differences in the national utility rates for CEA
in 2008. These reﬂect the proportion of asymptomatic patients, and
adherence to the RCTevidence base for intervention. The utility rate
of a representative year 2008 gave 6.0e13.5 operations per 100,000
inhabitants in the included area, lowest in Switzerland and highest
in Sweden. If only symptomatic patients would have been operated,
the corresponding utility rate varied between 3.6 in Switzerland
and 11.1 in Finland. Patel et al. presented a utility rate of 300/
100,000 Medicare beneﬁciaries (for people over 65 years). They
highlighted a nearly ninefold difference between the highest and
lowest rates of CEA across the US.17 The proportion of people over
65 years of age is around 12% in the US and not all are included in
Medicare; thus, the ﬁgures seem higher than the ones in Vascunet
countries. Taha et al. estimated that if all the patients in the most
effective group were operated upon (70% stenosis with TIA or
minor stroke), then the estimated need for CEAs would be 17.1 per
100,000 Finnish inhabitants.18
This article demonstrates that registry data can reveal national
differences in intervention rates with differing utility and effec-
tivity. Validation and critical analysis of registry data are in the
interests of patients, clinicians and politicians.Conclusions
Carotid surgery seems to be safe in all of the reporting coun-
tries and the outcome data compare well with the results from
RCTs and published register outcome data. There is no evidence
that CAS has been replacing CEA during recent years. There are
major differences in the theoretical stroke prevention potential of
the CEA practice in the participating countries. We recommend
P. Vikatmaa et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 11e17 17that the participating countries need to agree on standards for
national clinical audit.
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